This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Back
Prostate and breast cancer incidence rates have risen in Japan, emphasizing the need for precise histopathological diagnosis to determine patient prognosis and guide treatment decisions. Artificial intelligence algorithms have entered the clinical routine to increase precision and efficacy in patient care with growing malignancy numbers every year.
This study aimed to validate the performance and clinical utility of two artificial intelligence solutions, Galen Prostate and Galen Breast in detecting prostate and breast cancer in real-world clinical routine use in a Japanese cohort, also assessing their grading capabilities.
Click here to download the study:
Back
Articles
How ‘game-changing’ AI is helping discover cancer for the first time in UK | ITV News
Videos